Lingshuang Lü
Nanjing Medical University
7 Papers
Lingshuang Lü is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: microRNA & Population. The author has an hindex of 7, co-authored 7 publications.
Chat about Author
Papers
Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer.
TL;DR: Evidence is provided that circRNAs are differentially expressed in breast cancer and are important in carcinogenesis because they participate in cancer-related pathways and sequester miRNAs.
175
MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis.
TL;DR: Specific miRs could serve as potential prognostic biomarkers in TNBC and were found to be associated with shorter OS, while the levels ofMiR-454 and miR-374a/b expression were associated with DFS.
81
Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis
Min Wang,Guisheng Xu,Lingshuang Lü,Kun Xu,Yongzhong Chen,Hongqiu Pan,Bo Burström,Kristina Burström,Kristina Burström,Jianming Wang +9 more
TL;DR: It is suggested that genetic polymorphisms of IL-17 and TLR4 may play a role in host susceptibility to tuberculosis in the Chinese Han population and more work is necessary to identify specific causative variants of tuberculosis underlying the observed associations.
Family member-based supervision of patients with hypertension: a cluster randomized trial in rural China
Y Shen,X Peng,Min Wang,X Zheng,Guisheng Xu,Lingshuang Lü,Kun Xu,Bo Burström,Bo Burström,Kristina Burström,Kristina Burström,Jianming Wang +11 more
TL;DR: Findings from this study revealed that the family member-based supervised therapy may have positive effects on patients’ adherence to blood monitoring and hypertensive medications.
Prevalence, Awareness, Treatment and Control of Diabetes Mellitus in a Chinese Population
TL;DR: The high prevalence and inadequate awareness, treatment and control of DM in the Chinese population is highlighted and management and prevention of DM-related complications should be considered an essential strategy by governments and society.